report-image

Seasonal Affective Disorder Market Analysis By Type (Fall & Winter Seasonal Affective Disorder, Spring & Summer Seasonal Affective Disorder, Others), By Treatment (Self-Care, Psychotherapy, Phototherapy, Medications, Mind-Body Techniques, Others), By Diagnosis (Physical Exam, Laboratory Tests, Psychological Evaluation, Others), By End User (Hospitals, Clinics, Household, Medical Research Centers, Others) & Forecast

  • PUBLISHED ON
  • NO OF PAGES
  • 287
  • CATEGORY
  • Healthcare & Life Sciences
Market Segmentations:
The global seasonal affective disorder market size was valued at USD 550 million in 2021 and is projected to reach around USD 950 million in 2030 exhibiting a CAGR of 5.5% in the forecasted period. The growing prevalence and rising awareness of seasonal affective disorder are among the major factors boosting the industry growth. Conversely, the side effects produced because of the seasonal affective disorder medicines are hampering the market from growth.
Growing prevalence of seasonal affective disorder and depression globally is anticipated to propel growth of the seasonal affective disorder market throughout the forecasted period. For example, as per the World Health Organization (WHO), depression is a prominent cause of disability universally and is a foremost contributor to the overall global load of disease. Worldwide, nearly 5.0% of adults suffer from depression. Additionally, as per the Anxiety and Depression Foundation facts and statistics published in June 2022, comprehensive anxiety disorder affects 6.8 million adults or 3.1% of the United States inhabitants each year. Thus, the growing cases of depression and SADs around the globe are anticipated to boost the complete growth of the market calculated over the forecasted period.
Additionally, increasing number of treatment options and growing research and development (R&D) is estimated to boost growth of the seasonal affective disorder market. For example, in October 2021, Columbia Psychiatry faculty and avoMD, a next-gen clinical decision support platform, combined forces to develop a communicating smartphone application that will offer point-of-care treatment algorithms for major depression.

As the days get dimmer and temperatures dip in most areas of the nations, many people begin to feel the effects of seasonal affective disorder. With the COVID-19 epidemic, some may feel the effects of seasonal depression even more than normal. The world is in a much better situation than last winter with the COVID-19 vaccine and present rollout of booster shots, the ambiguity of where the pandemic is heading can make the mental distress seem never-ending. This in turn is projected to help in the growth of the market.

Type Insights
Based on the type, the global seasonal affective disorder market is bifurcated into fall & winter seasonal affective disorder, spring & summer seasonal affective disorder, and others. The fall & winter seasonal affective disorder segment is anticipated to boost the market growth in the estimated period. The factors affecting the market growth are increasing prevalence of fall & winter seasonal affective disorder. For example, as per an article issued in the Hindawi Publishing Corporation- Depression Research and Treatment, in December 2015, stated that 15% population of Canada experiences sub-syndromal type of seasonal affective disorder, winter blues.

Treatment Insights
Based on the treatment, the global seasonal affective disorder market is segmented into self-care, psychotherapy, phototherapy, medications, mind-body techniques, and others. The phototherapy segment accounts for the major share of the market. For example, as per an article issued in the National Center for Biotechnology Information (NCBI), in October 2020, declared that 60- 80% of seasonal affective disorder patient are aided from phototherapy.

End User Insights
Based on end user, the global seasonal affective disorder market is segmented into hospitals, clinics, household, medical research centers, and others. Owing to the rising patient population, the hospital's segment held the leading market share. This is mostly owing to the growing number of patients suffering from seasonal affective disorder that are treated in hospitals with advanced substructure and adequate amenities. Furthermore, the rising number of hospitals along with proper reimbursement policies is also donating to the growth of this segment.

Region Insights
North America is expected to dominate the global market in terms of market share during the forecasted period due to increase in prevalence of seasonal depression. About 5% of the population of the U.S. suffers from seasonal affective disorder. This is accredited to changing lifestyles and upsurge in awareness about seasonal depression and its cure.
However, Asia Pacific has less prevalence of seasonal affective disorder. Increase in awareness, growth in the geriatric population, and rise in medical tourism in emerging markets such as China and India are projected to increase the growth of the market in the region.

Key Companies Insights
The market for seasonal affective disorder is moderately competitive. With the rising applications of seasonal affective disorder, new players are considering to enter the market. The companies are also involved in events like joint ventures, acquisitions, partnerships, mergers, and collaborations. These activities aid in growing the effect of the players in the seasonal affective disorder market, ultimately boosting the market growth.

Some of the key companies working in the global seasonal affective disorder market include:
• Henry Schein Inc.
• Bristol-Myers Squibb
• Allergan
• Bayer AG
• Koninklijke Philips N.V.
• Bausch Health
• Mylan, Inc.
• F. Hoffmann-La Roche AG
• AbbVie Inc.
• Eli Lily and Company
• Sanofi
• Novartis AG
• GlaxoSmithKline
• Pfizer, Inc.
• Teva Pharmaceutical Industries Ltd.
• Johnson & Johnson Services Inc.
• Other players

Some of the Recent Developments:
• In February 2022, Granules India received authorization from the United States Food and Drug Administration to market Bupropion Hydrochloride extended-release tablets in the United States to treat the main depressive disorder and seasonal affective disorder.
• In June 2021, the United States Food and Drug Administration approved a new medicine for schizophrenia and bipolar illness by Alkermes plc. Lybalvi associates the active ingredient of Eli Lilly's Zyprexa with a novel chemical agent called samidorphan in a drug that will be sold as Lybalvi.

Segments
By Type
• Fall & Winter Seasonal Affective Disorder
• Spring & Summer Seasonal Affective Disorder
• Others

By Treatment
• Self-Care
• Psychotherapy
• Phototherapy
• Medications
• Mind-Body Techniques
• Others

By Diagnosis
• Physical Exam
• Laboratory Tests
• Psychological Evaluation
• Others

By End User
• Hospitals
• Clinics
• Household
• Medical Research Centers
• Others

By Geography
• North America
o U.S.
o Canada
o Mexico
• Europe
o U.K.
o Germany
o France
o Italy
o Spain
o Russia
• Asia-Pacific
o Japan
o China
o India
o Australia
o South Korea
o ASEAN
• Latin America
o Brazil
o Argentina
o Colombia
• MEA
o South Africa
o Saudi Arabia
o UAE
o Egypt

Quality Assurance Process

  1. We Market Research’s Quality Assurance program strives to deliver superior value to our clients.

We Market Research senior executive is assigned to each consulting engagement and works closely with the project team to deliver as per the clients expectations.

Market Research Process




We Market Research monitors 3 important attributes during the QA process- Cost, Schedule & Quality. We believe them as a critical benchmark in achieving a project’s success.

To mitigate risks that can impact project success, we deploy the follow project delivery best practices:
  • Project kickoff meeting with client
  • Conduct frequent client communications
  • Form project steering committee
  • Assign a senior SR executive as QA Executive
  • Conduct internal editorial & quality reviews of project deliverables
  • Certify project staff in SR methodologies & standards
  • Monitor client satisfaction
  • Monitor realized value post-project

Case Study- Automotive Sector

One of the key manufacturers of automotive had plans to invest in electric utility vehicles. The electric cars and associated markets being a of evolving nature, the automotive client approached We Market Research for a detailed insight on the market forecasts. The client specifically asked for competitive analysis, regulatory framework, regional prospects studied under the influence of drivers, challenges, opportunities, and pricing in terms of revenue and sales (million units).

Solution

The overall study was executed in three stages, intending to help the client meet its objective of precisely understanding the entire market before deciding on an investment. At first, secondary research was conducted considering political, economic, social, and technological parameters to get a gist of the various aspects of the market. This stage of the study concluded with the derivation of drivers, opportunities, and challenges. It also laid substantial emphasis on understanding and collecting data not only on a global scale but also on the regional and country levels. Data Extraction through Primary Research

The second stage involved primary research in which several market players and automotive parts suppliers were contacted to study their viewpoint concerning the development of their market and production capacity, clientele, and product line. This stage concluded in a brief understanding of the competitive ecosystem and also glanced through the strategies and pricing of the companies profiled.

Market Estimates and Forecast

In the final stage of the study, market forecasts for the electric utility were derived using multiple market engineering approaches. This data helped the client to get an overview of the market and accelerate the process of investment.

Case Study- ICT Sector

Business process outsourcing, being one of the lucrative markets from both supply- and demand- side, has appealed to various companies. One of the prominent corporations based out of Japan approached us with their requirements regarding the scope of the procurement outsourcing market for around 50 countries. Additionally, the client also sought key players operating in the market and their revenue breakdown in terms of region and application.


Business Solution

An exhaustive market study was conducted based on primary and secondary research that involved factors such as labor costs in various countries, skilled and technical labors, manufacturing scenario, and their respective contributions in the global GDP. A comparative study of the market was conducted from both supply- and demand side, with the supply-side comprising of notable companies, such as GEP, Accenture, and others, that provide these services. On the other hand, large manufacturing companies from them demand-side were considered that opt for these services.


Conclusion

The report aided the client in understanding the market trends, including country-level business scenarios, consumer behavior, and trends in 50 countries. The report also provided financial insights of crucial players and detailed market estimations and forecasts till 2033.


CHOOSE LICENSE TYPE
QLOUD
Pricing

Select a license type that suits your business needs

Single User Access

US $4250

Only Four Thousand Two Hundred Fifty US dollar

  • 1 User access
  • 15% Additional Free Customization
  • Free Unlimited post-sale support
  • 100% Service Guarantee until achievement of ROI
Multi User Cost

US $5250

Only Five Thousand Two Hundred Fifty US dollar

  • 5 Users access
  • 25% Additional Free Customization
  • Access Report summaries for Free
  • Guaranteed service
  • Dedicated Account Manager
  • Discount of 20% on next purchase
  • Get personalized market brief from Lead Author
  • Printing of Report permitted
  • Discount of 20% on next purchase
  • 100% Service Guarantee until achievement of ROI
Enterprise User Cost

US $6250

Only Six Thousand Two Hundred Fifty US dollar

  • Unlimited User Access
  • 30% Additional Free Customization
  • Exclusive Previews to latest or upcoming reports
  • Discount of 30% on next purchase
  • 100% Service Guarantee until achievement of ROI